Purchases and Sales Made in Q4 2020 in Processa Pharmaceuticals, Inc. (PCSA)
This table provides information about the institutional ownership of Processa Pharmaceuticals, Inc. (PCSA) during Q4 2020. The information is specifically focused on institutions that hold shares of Processa Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 16, 2021
Q4 2020
|
Solas Capital Management, LLC
Darien, CT |
BUY
|
- |
450KNew |
$1.78M - $3.82M
|
450K
$441K
|
|
Feb 12, 2021
Q4 2020
|
Essex Investment Management CO LLC
Boston, MA |
BUY
|
- |
74.9KNew |
$296K - $635K
|
74.9K
$73.4K
|
|
Jan 25, 2021
Q4 2020
|
Janney Montgomery Scott LLC
|
BUY
|
- |
66.3KNew |
$262K - $562K
|
66.3K
$65K
|
|
Feb 12, 2021
Q4 2020
|
Myda Advisors LLC
Inwood, NY |
BUY
|
- |
40.2KNew |
$159K - $340K
|
40.2K
$39.3K
|
|
Feb 16, 2021
Q4 2020
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.34KNew |
$5.31K - $11.4K
|
1.34K
$1.32K
|
|
Feb 12, 2021
Q4 2020
|
Evoke Wealth, LLC
|
BUY
|
- |
200New |
$790 - $1.7K
|
200
$196
|
|
Feb 09, 2021
Q4 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
41New |
$162 - $348
|
41
$40.2
|
|
Feb 02, 2021
Q4 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|